Longboard Pharmaceuticals Announces Pricing of Initial Public Offering
Longboard Pharmaceuticals Announces Pricing of Initial Public Offering March 11, 2021 21:44 ET | Source: Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc. San Diego, California, UNITED STATES SAN DIEGO, March 11, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a price to the public of $16.00 per share....
Source: globenewswire.com